Role of a genetic variation in the promoter of human thromboxane synthase gene in myocardial infarction.
- 1 November 2000
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 153 (1) , 261-262
- https://doi.org/10.1016/s0021-9150(00)00593-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controlsThe Lancet, 2000
- Variation of the factor VII gene and ischemic heart disease in Japanese subjectsCoronary Artery Disease, 1999
- The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromesAtherosclerosis, 1998
- Characterization of the Human Gene (TBXAS1) Encoding Thromboxane SynthaseEuropean Journal of Biochemistry, 1994
- Biochemical evidence of platelet activation in patients with persistent unstable anginaJournal of the American College of Cardiology, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975